We used a monoclonal anti-idiotypic antibody that is directed against a Sendai virus-specific helper Tcell clone to induce an anti-viral immune response in vivo. Splenocytes primed with the anti-idiotypic antibody mediated an antigen-specific cytolytic response. Preimmunization of mice with the anti-idiotypic antibody resulted in protection against a subsequent lethal infection with Sendai virus.
Jerne's network theory, initially formulated and experimentally supported for humoral responses (1), seems to apply as well to certain T-cell-mediated immune mechanisms (2) . Idiotypic antibodies have been shown to induce anti-idiotypic antibodies with complementary specificity (3, 4) . Induction of protective humoral immunity by vaccination of mice with a mixture of several monoclonal anti-idiotypic antibodies has been described recently for a trypanosomiasis model (5) .
Protection against many acute viral infections, such as murine influenza A (6) and ectromelia (7) virus infection, seems to depend upon T-cell-mediated immune mechanisms. Antibody-induced anti-idiotypic antibodies have been shown to induce T helper cells (8) (which activate B cells), T cells [which mediate a delayed-type hypersensitivity response (9, 10) ], and suppressor T cells (11) (which inhibit generation of effector T cells).
Auto-anti-idiotypic antisera directed against T-cell populations stimulate a mixed leukocyte reaction (12) . Several groups reported recently the generation of monoclonal antibodies by immunization of mice with cloned T-cell lines or hybridomas (13) (14) (15) . These antibodies bind to the T-cell clones used for immunization and immunoprecipitate a 90,000-dalton molecule that presumably represents the Tcell receptor (14) . Functionally, these antibodies inhibit or stimulate interleukin 2 production by these T-cell clones (13) (14) (15) . We have recently generated a monoclonal antibody against a cloned Sendai virus (SV)-specific T helper cell line. This IgM antibody binds specifically to a fraction of SV-specific T cells. In vivo this anti-idiotypic antibody stimulates an antiviral immune response.
MATERIAL AND METHODS
Mice. Female B10.D2 (H-2d) BALB/c (H-2d), DBA/2 (H2d), AJ (H-2a), and B10.BR (H-2") mice were purchased from The Jackson Laboratory and used at the age of 6-10 weeks.
Viruses. SV and influenza A/PR8 virus were prepared, titrated, and inactivated as been described (16) . Reovirus T-Cell Lines. The methods that were employed to generate SV-specific T-cell lines were described in detail earlier (16) . 2H3.E8 (2H3.E8.14 is a subclone) and 2H3.F10.F6 refer to cloned T-cell lines; 1G5 and 2G8 are uncloned, long-term Tcell lines that were derived from a limiting dilution assay.
Generation of Anti-Idiotypic B-Cell Hybridomas. Over a period of 6 months, B10.D2 mice were immunized intraperitoneally at 14-day intervals with 1-2 x 106 Ficoll-Isopaquepurified 2H3.E8 cells. Mice were sacrificed 1 week after the last immunization and splenocytes were fused with the myeloma line NS-1 (17) . Hybridoma culture supernatants were tested for binding to the clone used for immunization. Out of 48 different supernatants, 1 was found to be positive. Cells of this well were subcloned (1 cell per 10 flat-bottom microtiter plate wells). One subclone (designated 1B4.E6) was expanded and used for further studies. Culture supernatant of 1B4.E6 was precipitated three times with a saturated ammonium sulfate solution and reconstituted to a final protein concentration of 20 mg/ml (18) . The secreted immunoglobulin was identified as IgM by radial immunodiffusion. To ensure that 1B4.E6 was not directed against SV antigens, ammonium sulfate-precipitated culture supernatant was tested by hemagglutination inhibition assay (HIA) and an enzymelinked immunosorbent assay (ELISA) for anti-viral activity (19) . No anti-SV activity could be found by either assay.
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The cytolytic activity of lymphocytes stimulated under limiting-dilution conditions was tested after 6-7 days of incubation by transferring 35-75 ,ul of the effector cells onto 103 51Cr-labeled infected or uninfected tumor target cells. 51Cr release was measured after a 5-hr incubation. Cells of wells that showed 5tCr release more than three standard deviations above the mean of 5tCr release in the presence of cells from control wells were regarded as being positive. The number of input responder cells/wells that yielded 37% negative wells was used to define the frequency of SV-specific cytolytic T cells (22) .
Induction of Protective Immunity. Groups of five B1O.D2 mice were injected intraperitoneally three times in 4-day intervals with 200 ,l of 1B4.E6 or once with 103 HAU of SVuv or A/PR8 virus. Six days later these mice and naive control mice were inoculated intranasally with a lethal dose of infectious SV (1-2 x 101 HAU) or influenza virus A/PR8 (2 HAU). Five days later the virus in the lungs of infected mice was determined by titration in embryonated chicken eggs as described (23) .
RESULTS
We used a cloned T-cell line, designated 2H3.E8, to induce anti-idiotypic antibodies. According to its functions-i.e., secretion of lymphokines such as interleukin 2 in response to SV antigen-2H3.E8 was classified as a T helper cell clone (24) . Phenotypically 2H3.E8 was Thy-1.2+, Lyt-1-2-as described for allospecific T helper cell clones (20) .
Syngeneic B1O.D2 mice were used to raise anti-T-cell receptor antibodies. After fusion with NS-1 myeloma cells, the supernatant of cells of 1 well (out of 48 wells that contained growing hybridoma cells) was found to bind to 2H3.E8. After subcloning, the specificity of the antibody secreted by one subclone, which was designated 1B4.E6, was further investigated. We tested this antibody for binding to 2H3.E8 and 2H3.E8.14 and three other SV-specific proliferative Tcell lines (such as 1G5 and 2G8). All of these T-cell lines were derived from B1O.D2 splenocytes. The antibody bound to 2H3.E8 (data not shown), 2H3.E8.14 ( Fig. 1) , and one of the other T-cell clones (iG5) but failed to bind to two other T helper cell clones (2H3.F1O.F6 and 2G8 shown in Fig. 1 ) that were functionally identical to 2H3.E8. Of 16 SV-specific Tcell lines, 6 (37%) bound 1B4.E6 (one positive and one negative example are shown in Fig. 1 Because we found that the anti-T-cell antibody (1B4.E6) bound to more than one SV-specific clone while not binding to other T-cell clones, we hypothesized that the determinant recognized by 1B4.E6 might be a common SV-specific idiotype. Therefore we investigated its ability to stain T cells generated from cultures of in vitro stimulated spleen cells.
In the first set of experiments, T cells from naive BMO.D2 mice and from BMO.D2 mice that had been primed in vivo with SV or an unrelated virus (reovirus type 3) and subsequently restimulated in vitro with SV or reovirus type 3 were tested for binding by 1B4.E6 or anti-Thy-1.2 antibodies (Fig.  2) . Neither spleen cells from unimmunized mice stimulated in vitro with SV nor spleen cells from mice primed in vivo that were restimulated in vitro with reovirus type 3 bound the anti-idiotypic antibody. A significant number of T cells from SV-immune mice that were restimulated in vitro with SV were stained by 1B4.E6. The percentage of cells stained varied from 4% to 30% of all T cells in an SV-specific secondary culture in vitro.
In the next set of experiments we examined stimulation of a virus-specific cytolytic T-cell response by immunization of mice with the anti-idiotypic antibody (1B4.E6). We primed mice of different haplotypes (which differ in H-2 or Igh-J genes or both) with the anti-idiotypic antibody, SV, or influenza A/PR8 virus (as a control). Splenocytes were restimulated in vitro with SVuv or A/PR8 virus and subsequently tested for cytolytic activity on infected and uninfected target cells ( Table 1 ). Splenocytes that had been primed and restimulated with virus lysed, as expected, the appropriate infected target cells. Unprimed splenocytes that had only been stimulated with SVuv in vitro failed to cause significant lysis. (Fig. 3 Upper). The high frequency of anti-SV cytolytic T cells in mice that had been injected with the anti-idiotypic antibody should be considered in the context of the high dose of antibody injected and the relatively low dose of inactivated SV we used. The overall lysis mediated by anti-idiotype primed T cells was, in most experiments, lower than lysis mediated by SV-immune T cells (Fig. 3 Lower), which is consistent with the results of bulk culture cytolytic lymphocytes obtained in Table 1 .
T cells recognize foreign antigens in association with self antigens encoded by the major histocompatibility complex. Experiments using bulk culture analysis of spleen cells from animals immunized with SV or anti-idiotype had indicated that the anti-idiotype-induced T-cell response was less H-2 restricted-i.e., showed more crossreactivity on SV-infected allogeneic target cells than did cytolytic T lymphocytes induced by SV. To better quantitate this crossreactivity, limiting numbers of cells from SV-immunized mice ( (Fig. 4) . A responder cell dilution was chosen at which only /4-1/3 of the wells showed significant lysis of the SV-infected syngeneic target cells (14 out of 48 wells for SV-immune splenocytes; 36 out of 96 wells for 1B4.E6-immune splenocytes), and thus presumably contained clonally derived T cells. Most of the SV-induced T cells were specific for syngeneic virus-infected target cells. Only 3 out of 14 positive wells (i.e., 21%) had 
DISCUSSION
The principal goal of the studies reported here was to determine whether an anti-idiotypic antibody made against a virus-specific T-cell clone could induce a virus-specific immune response in vivo. This anti-idiotypic antibody was induced by multiple immunizations of B1O.D2 mice with a SVspecific T helper cell clone (23 (Fig. 4) .
To determine if it is possible to protect mice against a lethal SV infection by preimmunization with anti-idiotypic antibody, groups of five mice were immunized either three times in 4- distinct populations of T cells. The evidence of more crossreactivity in the anti-idiotype-stimulated mice invites the speculation that the affinity of the anti-idiotypic antibody for the T-cell receptor of some T precursor lymphocytes is high enough to cause direct stimulation-i.e., without processing and presentation in context with H-2. T cell clones that are directly stimulated by the anti-idiotype might have a high enough affinity to the viral antigen to override H-2 restriction. Viral antigen that becomes integrated into the cell membrane and thus associated with H-2 molecules, on the other hand, might stimulate (predominantly) T-cell clones with low affinity for viral antigen and moderate affinity for self H-2.
Anti-idiotypic antibodies that were induced against idiotypic antibodies have been shown previously to induce Tcell-mediated immunity. Auto-anti-idiotypic antibodies directed against allo-specific T-cell populations can stimulate a proliferative T-cell response as well as cytolytic T lymphocytes (12) . Anti-idiotypic antibodies, directed against antigen-specific T-cell clones, have been shown to stimulate or inhibit T-cell functions in vitro (13, 14) .
We 
